Liquid crystalline phase drug delivery vehicle
US6235312A · kind A · utility
13Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 1999 |
| Grant date | May 22, 2001 |
| Priority date | — |
| Expiry date | May 14, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S516/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The composition disclosed herein comprises about 55 to about 90 weight percent of a monoglyceride component comprising a monoglyceride having an acyl chain of 12 to 22 carbons, about 5 to about 35 weight percent of an acetylated monoglyceride component comprising an acetylated monoglyceride having an acyl chain of 12 to 22 carbons, and about 2 to about 40 weight percent water. The present composition is a liquid crystalline phase composition at a temperature of about 20 to about 80.degree. C., preferably a cubic liquid crystalline gel.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.